Table 1.
Criteria for level of evidence and grading of strength of recommendations used in formulation of present document.
| Quality of evidence | Level |
| Evidence from ≥1 good quality and well-conducted randomized control trial(s) or meta-analysis of RCT's | 1 |
| Evidence from at least 1 RCT of moderate quality, or well-designed clinical trial without randomization; or from cohort or case-controlled studies | 2 |
| Evidence from descriptive studies, or reports of expert committees, or opinion of respected authorities based on clinical experience | 3 |
| Not backed by sufficient evidence; however, a consensus reached by the working group, based on clinical experience and expertise | Useful Practice Point (UPP) |
| Strength of recommendations | Grade |
| Strong recommendations to do (or not to do) where the benefits clearly outweigh the risk (or vice versa) for most, if not all patients | A |
| Weak recommendations, where benefits and risk are more closely balanced or are more uncertain | B |